103 Results for "

Ce(d18:0/18:0)-d3

" in MedChemExpress (MCE) Product Catalog:
Products (103)

103 Results for "Ce(d18:0/18:0)-d3" in MCE Product Catalog:

Cat. No.: HY-N15851
CAS No.: 82014-84-4
Category:  

Lipids

Target:  

Drug Derivative

C24 Glucosyl(β) ceramide (d18:1/24:0), C24-Ceramide (d18:1/24:0) (HY-134508A) derivative, is a β-glucosyl ceramide and can be used for the research of lipid.
loading...
    loading...
Cat. No.: HY-134508A
CAS No.: 102917-80-6
Purity:  99%
Research Areas:  

Others

C24-Ceramide (d18:1/24:0) is a sphingolipid that can be used for the lipid membranes composed. C24-Ceramide (d18:1/24:0) induces time-dependent changes in membrane properties. C24-Ceramide (d18:1/24:0) induces membrane reorganization .
loading...
    loading...
Cat. No.: HY-164236
CAS No.: 119242-44-3
Target:  

Endogenous Metabolite

Research Areas:  

Metabolic Disease

C22 Glucosylceramide (d18:1/22:0) is a bioactive sphingolipid composed of a d18:1 sphingoid base and a 22:0 fatty acid chain. C22 Glucosylceramide (d18:1/22:0) specifically exists in Doxorubicin (HY-15142A)-sensitive cancer cells, and its circulating concentration is positively correlated with the incidence of cardiovascular events. C22 Glucosylceramide (d18:1/22:0) has been widely used in research related to cardiovascular diseases, hypercholesterolemia, metabolic syndrome, breast adenocarcinoma and other fields .
loading...
    loading...
Cat. No.: HY-144501
CAS No.: 2230218-36-5
Purity:  98.14%
D18 is an immune modulator. D18 acts as a TLR7/8 dual agonist (EC50 = 24 nM for hTLR7 and 10 nM for hTLR8, respectively). D18 increases PD-L1 expression through epigenetic regulation, thus sensitizing tumors to PD-1/PD-L1 blockade. D18 is a ADC cytotoxin uesd for the systhesis of ADC HE-S2 (HY-144497). D18 has strong immune activation and anti-tumor activity. D18 commonly used in cancer research, such as colon cancer .
loading...
    loading...
Cat. No.: HY-153830
CAS No.: 4201-62-1
Synonyms: C16 Lactosylceramide (d18:1/16:0)
LacCer (d18:1/16:0) (C16 Lactosylceramide (d18:1/16:0)) is an endogenous bioactive sphingolipid that can form membrane microdomains with Lyn kinase and the αi subunits of inhibitory G protein-coupled receptors (GPCRs). The levels of LacCer (d18:1/16:0) are elevated in the plasma of insulin-resistant cattle. In a mouse model of Niemann-Pick type C1 disease (a neurodegenerative cholesterol-sphingolipid lysosomal storage disorder), the expression of LacCer (d18:1/16:0) is also upregulated. LacCer (d18:1/16:0) can be used in research on metabolic diseases and neurodegenerative diseases .
loading...
    loading...
Cat. No.: HY-W341625
CAS No.: 474943-80-1
Trihexosylceramide (d18:1/12:0) is a glycosphingolipid and mood-related compound. Trihexosylceramide (d18:1/12:0) is characterized by elevated serum levels in Mus musculus fed a high-fat diet, and its levels are positively correlated with mood Z-scores. Accumulation of Trihexosylceramide (d18:1/12:0) in tissues is considered the etiology of angiokeratoma corporis diffusum. Trihexosylceramide (d18:1/12:0) can be used in studies related to high-fat diet-induced mood disorders .\n


loading...
    loading...
Cat. No.: HY-170035
CAS No.: 95119-86-1
Synonyms: C18 Glucosyl(β) ceramide (d18:1/18:0); D-glucosyl-β-1,1' N-stearoyl-D-erythro-sphingosine
Target:  

Fungal Wnt β-catenin

Research Areas:  

Infection Neurological Disease Cancer

GlcCer (d18:1/18:0) (C18 Glucosyl(β) ceramide (d18:1/18:0)) is a glycosphingolipids that activates the Wnt/β-catenin pathway by targeting LRP6. GlcCer (d18:1/18:0) drives EMT, migration, invasion and GBA1-mediated liver cancer metastasis. GlcCer (d18:1/18:0) accumulates to impair lysosomal function and induce toxic α-synuclein aggregation. GlcCer (d18:1/18:0) supports growth, sporulation, germination and virulence in Penicillium digitatum. GlcCer (d18:1/18:0) is reduced in demyelinated mouse corpus callosum. GlcCer (d18:1/18:0) can be used for the research of liver cancer, synucleinopathies, fungal, Parkinson’s disease and Gaucher disease .
loading...
    loading...
Cat. No.: HY-W923642
CAS No.: 474923-21-2
Sphingomyelin (d18:1/12:0) is a metabolomic biomarker. Sphingomyelin (d18:1/12:0) exhibits favorable diagnostic properties and may facilitate the early detection and targeted prevention of dyslipidemia-related adverse cardiovascular events .
loading...
    loading...
Cat. No.: HY-145472
CAS No.: 954096-91-4
Research Areas:  

Cancer

Sphingosine (d18:1) alkyne (compound 2b) is an alkyne-labeled Sphingosine (d18:1) that can be used in click chemistry reactions .
loading...
    loading...
Cat. No.: HY-156209
CAS No.: 137896-85-6
Research Areas:  

Cardiovascular Disease Cancer

Gb3 (d18:1/16:0) (Compound 1) is the P k antigen of the P blood group system. Gb3 (d18:1/16:0) acts as a cell surface receptor. Gb3 (d18:1/16:0) is used for research on Burkitt's lymphoma, teratocarcinoma, embryonal carcinoma, and Fabry's disease .
loading...
    loading...
Cat. No.: HY-146929S
CAS No.: 2342574-42-7
Research Areas:  

Others

18:1 SM (d18:1/18:1)-d9 is deuterium labeled 18:1 SM (d18:1/18:1).
loading...
    loading...
Cat. No.: HY-N10706A
CAS No.: 35299-94-6
Target:  

Endogenous Metabolite

Research Areas:  

Cardiovascular Disease

3-Keto sphinganine (d18:0) hydrochloride serves as the substrate for 3-keto-dihydrosphingosine reductase in the de novo sphingolipid synthesis pathway, and is a key intermediate in the de novo synthesis of sphingoid long-chain bases. 3-Keto sphinganine (d18:0) hydrochloride can be used in studies related to thrombocytopenia, anemia .
loading...
    loading...
Cat. No.: HY-156206
CAS No.: 6063-36-1
Purity:  ≥99.0%
Target:  

Drug Derivative

Research Areas:  

Metabolic Disease

C24 Dihydro ceramide (d18:0/24:0) is an ester product.
loading...
    loading...
Cat. No.: HY-N15841
CAS No.: 67492-18-6
Category:  

Animals Lipids

Target:  

Ceramidase

C25 Ceramide (d18:1/25:0) is an endogenous ultra-long-chain ceramide that antagonizes the detrimental effects of long-chain ceramides on insulin sensitivity. C25 Ceramide (d18:1/25:0) is specifically enriched in oxidative skeletal muscle fibers, where it serves dual roles in providing structural support to cell membranes and regulating cellular signaling. By participating in the regulation of lipid homeostasis within muscle fibers, C25 Ceramide (d18:1/25:0) helps maintain normal insulin signaling. C25 Ceramide (d18:1/25:0) is primarily utilized in research concerning metabolic diseases—particularly in mechanistic studies investigating the muscle fiber type-specific aspects of insulin resistance .
loading...
    loading...
Cat. No.: HY-177888
CAS No.: 111142-68-8
Research Areas:  

Endocrinology

Lc2Cer(d18:1, 22:0) is a lactosylceramide containing d18:1, C22:0 ceramides. Lc2Cer(d18:1, 22:0) can be used for renal cortical epithelial cell research .
loading...
    loading...
Cat. No.: HY-146930S
CAS No.: 2342574-45-0
Research Areas:  

Others

16:1 SM (d18:1/16:1)-d9 is deuterium labeled 16:1 SM (d18:1/16:1).
loading...
    loading...
Cat. No.: HY-146933S
CAS No.: 2342574-54-1
24:1 SM (d18:1/24:1)-d9 is deuterium labeled 24:1 SM (d18:1/24:1).
loading...
    loading...
Cat. No.: HY-N15352
CAS No.: 222403-67-0
Target:  

Liposome

C20 Sphingomyelin (d18:1/20:1) is a sphingomyelin substance. The level of C20 Sphingomyelin (d18:1/20:1) is associated with amyotrophic lateral sclerosis and primary lateral sclerosis .
loading...
    loading...
Cat. No.: HY-145467
CAS No.: 1246303-22-9
Purity:  98%
Synonyms: C16 Ceramide-1-phosphate ammonium; Ceramide-1-phosphate (d18:1/16:0) ammonium; CerP(d18:1/16:0) ammonium
Research Areas:  

Metabolic Disease

C16 Ceramide-1-phosphate (d18:1/16:0) ammonium (C16 Ceramide-1-phosphate ammonium; Ceramide-1-phosphate (d18:1/16:0) ammonium) is an ester product that can be used to synthesize nanobiomaterials.
loading...
    loading...
Cat. No.: HY-N8016S
CAS No.: 1466552-36-2
Nonanal-d18 is the deuterium labeled Nonanal . Nonanal is a saturated fatty aldehyde with antidiarrhoeal activity .
loading...
    loading...